Purified Anti-Human CD19 Antibody[4G7]

Introducing the Purified Anti-Human CD19 Antibody [4G7], a highly effective and reliable solution for targeted immunotherapy. This antibody has been specifically designed to target the CD19 antigen, which is expressed on the surface of B cells and is a key marker for various B cell malignancies. The antibody has undergone rigorous purification processes to ensure its purity and potency, making it an ideal choice for research and clinical applications.

The Purified Anti-Human CD19 Antibody [4G7] has been extensively tested for its specificity and efficacy, and has demonstrated exceptional binding affinity to the CD19 antigen. Its high selectivity and low cross-reactivity with other antigens make it a valuable tool for the detection and isolation of CD19-expressing cells. Additionally, the antibody has been shown to induce potent cytotoxicity against CD19-positive cells, making it a promising candidate for targeted cancer therapy.

This product is manufactured to the highest standards of quality and purity, and is available in various formats to suit different applications. Whether you are conducting research in the field of immunology or developing novel therapies for cancer, the Purified Anti-Human CD19 Antibody [4G7] is an indispensable tool that can help you achieve your goals. Order now and experience the exceptional performance and reliability of this cutting-edge antibody.